Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

(-)-(2R)-3-(2-hydroxymethylindanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate

EU orphan designation number: EU/3/08/560   
Active ingredient: (-)-(2R)-3-(2-hydroxymethylindanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
Indication: Treatment of moderate and severe closed traumatic brain injury
Sponsor: KeyNeurotek Pharmaceuticals AG
Zenit-Technology Park Leipzigerstraße 44, 39120 Magdeburg, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/09/2008 Orphan designation EMEA/OD/007/07 (2008)5021 of 05/09/2008